326.1 A novel Australian medical device (Organ Angel) for oxygenated hypothermic perfusion of donor hearts in a porcine model for up to 6 hours.
Dr. James E Besanko, Australia
326.2 Lifetime management after continuous-flow LVAD implantation as bridge to transplantation
Prof. Minoru Ono, Japan
326.3 Is it worth using hearts with more than 4 hours ischemic time? Results from 528 consecutive heart transplants at a reference center in Brazil
Dr. Ronaldo H B Santos, Brazil
326.4 Dynamics of physical and mental quality of life long-term after heart transplantation
Dr. Maria Simonenko, Russian Federation
326.5 Relationship between tissue IgG plasma cells and serum donor-specific antibodies in cardiac allograft recipients with repeated antibody-mediated rejection
Dr. Gonca Ozgun, Turkey
326.6 Evaluation of morbidity and mortality in patients over 65 years of age with left ventricular assist device implantation
Dr. Deniz Sarp Beyazpinar, Turkey
326.7 Venoarterial extracorporeal membrane oxygenation support for heart transplantation: 10 years’ experience